Enforcement Report - Week of January 31, 2024
Poison control centers in the U.S. have seen an increase in reports of children ingesting a type of prescription cough medicine, a study published Tuesday by the Food and Drug Administration found.
Puracap Pharm's Generic Benzonatate Receives Approval in US
Aiping Pharm`s Generic Benzonatate Receives Approval in US
Enforcement Report - Week of May 31, 2017
American Health Packaging, Ongoing Class II recall of Benzonatate Capsules, USP, 100 mg, 100 count (10X10), Rx only, Packaged and Distributed by: American Health Packaging Columbus, Ohio 43217 --- NDC 68084-214-01(carton) NDC 68084-214-11 (individual dose) because of Failed Tablet/Capsule Specifications; recall initiated by manufacturer due to reports of wet capsules
Zydus Pharmaceuticals USA Inc, Ongoing Class II recall of Benzonatate Capsules, USP, 100 mg, Rx only, Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India; Distributed by: Zydus Pharmaceuticals USA, In, Pennington, NJ USA 08534; 100-bottle capsules - NDC 68382-247-01 500-bottle capsules - NDC 68382-247-05 because of Failed Tablet/Capsule Specifications: Recall due to wet and/or leaking capsules.